Street Watchdog Research Cautious on Myriad Genetics (MYGN)
Tweet
Share
E-mailGet Alerts MYGN Hot Sheet
Price: $17.98 --0%
Rating Summary:
8 Buy, 15 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 17 | New: 5
Rating Summary:
8 Buy, 15 Hold, 5 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 17 | New: 5
Join SI Premium – FREE
Street Watchdog Research issued negative commentary on Myriad Genetics (NASDAQ: MYGN), saying they see two major headwinds that will likely pressure the stock.
The two headwinds, which they label as 'Little Boy' and 'Fat Man', are:
- The potential for INCREASED COMPETITION resulting from a lack of patent protection (Little Boy)
- LIMITATIONS ON PRICING as a result of increasing health care costs being brought to the forefront of political thought (Fat Man)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AppFolio (APPF) PT Raised to $275 at KeyBanc
- Erste Group Downgrades Apple (AAPL) to Hold, 'new products do not currently have the potential to significantly improve momentum'
- DA Davidson Starts Napco Security Technologies, Inc. (NSSC) at Buy
Create E-mail Alert Related Categories
Analyst CommentsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
